Inhibikase Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $396k | 235k | 1.68 |
| 2025-12-31 | $312k | 152k | 2.05 |
| 2025-09-30 | $247k | 152k | 1.62 |
| 2025-06-30 | $297k | 152k | 1.95 |